McCabe Sarah M, Smith Patrick F, Ma Qing, Morse Gene D
Associate Dean, Clinical Education and Research, University of Buffalo, Department of Pharmacy Practice, 317 Hochstetter Hall, Buffalo, NY 14260, USA.
Expert Opin Drug Metab Toxicol. 2007 Apr;3(2):197-207. doi: 10.1517/17425255.3.2.197.
Gastroesophageal reflux disease and other related symptoms are common comorbidities for HIV-infected patients. Therefore, concurrent use of proton pump inhibitors and antiretrovirals is a common practice in the clinical setting. However, this practice may alter antiretroviral pharmacokinetics and lead to treatment failure due to inadequate drug exposure. Clinician awareness of these complex interactions is essential for optimal HIV management. This review summarizes the current knowledge on the interactions between proton pump inhibitors and antiretrovirals, and makes recommendations for the coadministration of proton pump inhibitors.
胃食管反流病及其他相关症状是HIV感染患者常见的合并症。因此,在临床环境中同时使用质子泵抑制剂和抗逆转录病毒药物是一种常见的做法。然而,这种做法可能会改变抗逆转录病毒药物的药代动力学,并因药物暴露不足而导致治疗失败。临床医生了解这些复杂的相互作用对于优化HIV管理至关重要。本综述总结了目前关于质子泵抑制剂与抗逆转录病毒药物相互作用的知识,并对质子泵抑制剂的联合使用提出建议。